Robert Edward Mehler
Physician at Eldorado Spg Dr, Boulder, CO

2013008, Apr 4, 2013

Sep 28, 2012

13/631567

Stephen Alaric WILLIAMS - Boulder CO, US
Alex A.E. STEWART - Waltham MA, US
Robert MEHLER - Boulder CO, US
Trudi FOREMAN - Boulder CO, US
Britta SINGER - Boulder CO, US

SOMALOGIC, INC. - Boulder CO

C40B 30/04, C40B 40/06, C40B 40/10

506 9, 506 18, 506 16

The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the evaluation of risk of a caradiovascular (CV) Event within 5 years. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to evaluate risk of a CV event within 5 years. In another aspect, methods are provided for evaluating risk of a CV event within 5 years in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1. In a further aspect, methods are provided for evaluating the risk of a CV, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 2. In a further aspect, methods are provided for evaluating the risk of a CV event in an individual, generally within 5 years, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 3.